about
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.Conjugated amino acids in plasma of patients with uremiaPhenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.Colonic contribution to uremic solutes.Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addictionUrinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disordersThe kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.A radiochemical assay for glycine N-acyltransferase activity. Some properties of the enzyme in rat and rabbit.Saline is as effective as nitrogen scavengers for treatment of hyperammonemia.Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis.Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.
P2860
Q33939797-B22B6BC3-F4FA-46FA-9149-3D5285BD0EF2Q34013000-4072F511-5F34-4A07-8B26-1911B277696CQ34983962-82BA3914-2717-4D8D-9AC5-970778BDFC84Q35210230-4E836FF2-AD42-44F3-86C5-A841634D1448Q35287869-25D535E4-C912-46BB-8FC5-1E995EE1F981Q36717438-ABF537F7-E998-49C9-A389-75EF43739116Q37069054-B8A35FD5-5FEB-4639-9A06-6C2EFF5D68ECQ37582146-82542B48-1B7F-4D77-9D5A-C981B3AA2AB9Q40372756-92304403-DDEB-4AE6-A531-18168432FBBBQ41823047-FCD06265-2917-41EE-BB97-85DE994FB622Q42377183-B3B8CF4B-C2A2-42CB-8AED-8B83413F6EF4Q42748628-9528158C-6C4A-4CF1-AF42-67673E722A97Q42931855-BEB2E1E9-29B4-4C72-AC14-9CE7A4475DA8
P2860
description
1957 nî lūn-bûn
@nan
1957 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1957 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1957年の論文
@ja
1957年論文
@yue
1957年論文
@zh-hant
1957年論文
@zh-hk
1957年論文
@zh-mo
1957年論文
@zh-tw
1957年论文
@wuu
name
Synthesis of phenylacetylglutamine by human tissue.
@ast
Synthesis of phenylacetylglutamine by human tissue.
@en
Synthesis of phenylacetylglutamine by human tissue.
@nl
type
label
Synthesis of phenylacetylglutamine by human tissue.
@ast
Synthesis of phenylacetylglutamine by human tissue.
@en
Synthesis of phenylacetylglutamine by human tissue.
@nl
prefLabel
Synthesis of phenylacetylglutamine by human tissue.
@ast
Synthesis of phenylacetylglutamine by human tissue.
@en
Synthesis of phenylacetylglutamine by human tissue.
@nl
P1476
Synthesis of phenylacetylglutamine by human tissue
@en
P2093
P304
P407
P577
1957-11-01T00:00:00Z